Publicacións en colaboración con investigadores/as de Universidade da Coruña (91)

2024

  1. Challenges in the Implementation of the Spanish Consensus on the Reduction of Oral Corticosteroids: Insights From the Medical Community

    Open Respiratory Archives, Vol. 6, Núm. 3

  2. Home Respiratory Therapies: SEPAR Technical Document for Institutional Decision Support

    Open Respiratory Archives, Vol. 6, Núm. 2

  3. Spanish Consensus on Remission in Asthma (REMAS)

    Archivos de Bronconeumologia

2023

  1. A Study of the Prevalence of Asthma in the General Population in Spain

    Open Respiratory Archives, Vol. 5, Núm. 2

  2. Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: orbe II study

    Respiratory research, Vol. 24, Núm. 1, pp. 235

  3. COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients

    BMC Health Services Research, Vol. 23, Núm. 1

  4. Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease

    Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 556-565

  5. Identification of Asthma Phenotypes in the Spanish MEGA Cohort Study Using Cluster Analysis

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 223-231

  6. Potential impact of mepolizumab in stepping down anti-osteporotic treatment in corticosteroid-dependent asthma

    Frontiers in Pharmacology, Vol. 14

  7. Quality indicators in the rational management of severe asthma: A Spanish multidisciplinary consensus

    Journal of Healthcare Quality Research, Vol. 38, Núm. 5, pp. 277-283

  8. REDES Study: Mepolizumab Is Effective in Patients With Severe Asthma and Comorbid Nasal Polyps

    Journal of Investigational Allergology and Clinical Immunology

  9. Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin

    International Journal of COPD, Vol. 18, pp. 1691-1700

  10. Residual pulmonary infiltrates, symptoms and diffusion impairment at 1-year after severe COVID-19 infection have different associated factors

    Journal of Internal Medicine, Vol. 294, Núm. 1, pp. 69-82

  11. Telemedicine and severe asthma in our environment: Views on the experience of professionals and suggestions to make it a reality

    Open Respiratory Archives, Vol. 5, Núm. 3

  12. The ATLAS ASMA Study: Assessing the Impact of Asthma on Patients’ Life – The Spanish Patients’ Perspective

    Journal of Asthma and Allergy, Vol. 16, pp. 461-471

  13. Transition of Adolescents With Severe Asthma From Pediatric to Adult Care in Spain: The STAR Consensus

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 3, pp. 179-189

  14. Treatment Patterns of Monoclonal Antibodies in Patients With Severe Uncontrolled Asthma Treated by Pulmonologists in Spain

    Open Respiratory Archives, Vol. 5, Núm. 3

  15. Validation of the Algorithm for the Monitoring and Control of Asthma Through Telemedicine: The COMETA Project

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 3, pp. 223-225

  16. Validation of the Asthma Impairment and Risk Questionnaire in Spain: A Useful Tool for Assessing Asthma Control in Adolescents and Adults

    Journal of Investigational Allergology and Clinical Immunology

  17. What's New in the 2022 Consensus for Severe Asthma in Adults

    Archivos de Bronconeumologia